← Back to Search

Other

Fat Injection for Carpal Tunnel Syndrome

Phase < 1
Waitlist Available
Led By Melvin P Rosenwasser, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year post-treatment
Awards & highlights

Study Summary

This study applies the regenerative properties of autologous fat transfer to treat mild to moderate carpal tunnel syndrome in comparison to the current standard of care, corticosteroid treatment. The investigators hypothesize the fat transfer would prevent scar formation and aid in nerve excursion along the canal (while the neoangiogenic and regenerative growth factors could stimulate nerve regeneration) better than the standard of care treatment.

Eligible Conditions
  • Carpal Tunnel Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional Outcome Score
Secondary outcome measures
Score on the Brigham Women's Carpal Tunnel Questionnaire
Score on the Michigan Hand Questionnaire (MHQ)

Side effects data

From 2018 Phase 4 trial • 1670 Patients • NCT02261727
32%
COPD Exacerbation - not hospitalised
16%
COPD Exacerbation - Hospitalised
7%
Upper Respiratory Tract Infection
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Low-dose Theophylline Arm
Theophylline and Prednisone Arm

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Fat InjectionExperimental Treatment1 Intervention
Subjects with CTS will receive fat injection.
Group II: Steroid InjectionActive Control1 Intervention
Subjects with CTS will receive steroid injection.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,447,709 Total Patients Enrolled
Orthopaedic Scientific Research FoundationUNKNOWN
Melvin P Rosenwasser, MDPrincipal InvestigatorDepartment of Orthopaedic Surgery at Columbia University Medical Center
2 Previous Clinical Trials
700 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome
Melvin Rosenwasser 2016. "Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03722303.
All > Carpal Tunnel
~12 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top